T8305 |
Ellagic acid (hydrate)
|
314041-08-2
|
98%
|
|
Ellagic acid hydrate is a natural antioxidant and acts as a potent and ATP-competitive CK2 inhibitor (IC50:40 nM, Ki: 20 nM).
|
T10829 |
CKI-7 free base
|
120615-25-0
|
98%
|
|
CKI-7 free base is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor. CKI-7 free base...
|
T16507 |
PF-5006739
|
1293395-67-1
|
98%
|
|
PF-5006739 is an effective and selective inhibitor of CK1δ/ε (IC50s: 3.9 nM and 17.0 nM, respectively). PF-5006739 is a potential therapeutic agent for a range o...
|
T71339 |
BMS-863233 HCl
|
1169562-71-3
|
98%
|
|
BMS-863233 HCl is an ATP-competitive Cdc7 inhibitor (IC50: 3.4 nM) that is potent and selective.BMS-863233 HCl inhibited CK2 and PIM1 with IC50 values of 215 and...
|
T77500 |
Casein kinase 1δ-IN-6
|
1579991-01-7
|
98%
|
|
Casein kinase 1δ-IN-6 is a potent and selective inhibitor of the protein kinase CK-1δ with an IC50 of 23 nM.Casein kinase 1δ-IN-6 shows neuroprotective and anti-...
|
T35557 |
CK2 inhibitor 2
|
2641079-92-5
|
98%
|
|
CK2 inhibitor 2 is a potent, selective and orally active CK2 inhibitor, with an IC 50 of 0.66 nM. CK2 inhibitor 2 shows high selectivity for Clk2 (IC 50 =32.69 n...
|
T8987 |
Epiblastin A
|
16470-02-3
|
98%
|
|
Epiblastin A is an inhibitor of Casein Kinase 1 (CK1). Epiblastin A engages CK1 isoenzymes in cell lysate and induces efficient conversion of epiblast stem cells...
|
T3972 |
SR-3029
|
1454585-06-8
|
98%
|
|
SR 3029 is a potent and highly specific CK1δ/CK1ε inhibitor.
|
T19913 |
CKI-7
|
1177141-67-1
|
98%
|
|
CKI-7 2HCl is an inhibitor of casein kinase 1 (CK1).
|
T10547 |
BioE-1115
|
1268863-35-9
|
98%
|
|
BioE-1115 is a selective and potent inhibitor of serine-threonine protein kinase (PASK, IC50 = 4 nM). BioE-1115 is a potent inhibitor of CK2α (IC50 = 10 μM).
|
T1828 |
TTP 22
|
329907-28-0
|
98%
|
|
TTP 22 is a high affinity, ATP-competitive casein kinase 2 (CK2) inhibitor with IC50/Ki of 0.1 uM/40 nM, and shows selectivity >250-fold for CK2 over JNK3, ROCK1...
|
T14072 |
A-443654
|
552325-16-3
|
98%
|
|
A-443654 is a pan-Akt inhibitor. It has equal potency against Akt1, Akt2, or Akt3 within cells (Ki=160 pM).
|
T7949 |
NCC007
|
2342583-66-6
|
98%
|
|
NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin.
|
T1877 |
LH846
|
639052-78-1
|
98%
|
|
LH846 is a selective inhibitor of CK1δ (IC50 values are 290 nM, 1.3 uM and 2.5 uM for CK1δ, ε and α); exhibits no inhibitory activity at CK2.
|
T5056 |
PF-4800567
|
1188296-52-7
|
98%
|
|
PF-4800567 is a selective inhibitor of casein kinase 1ε (CK1ε; IC50 = 32 nM) with greater than 20-fold selectivity over CK1δ.
|
T12237 |
NMS-P715
|
1202055-32-0
|
98%
|
|
NMS-P715 is a selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM).
|
T60005 |
WAY-296817
|
349438-74-0
|
98%
|
|
WAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, inf...
|
T5393 |
CK1-IN-1
|
1784751-20-7
|
98%
|
|
CK1-IN-1, compound 1c reported in patent WO2015119579A1, is a casein kinase 1 (CK1) inhibitor. It has IC50s of 15 nM, 16 nM, 73 nM for CK1δ, and CK1ε, p38σ MAPK,...
|
T10827 |
CK2/ERK8-IN-1
|
1085822-09-8
|
98%
|
|
CK2/ERK8-IN-1 is a dual inhibitor of casein kinase 2 (CK2) (Ki: 0.25 µM) and ERK8 (IC50s: 0.50 μM) with pro-apoptotic efficacy. CK2/ERK8-IN-1 also binds to PIM1,...
|
T2695 |
TBB
|
17374-26-4
|
98%
|
|
TBB(NSC 231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2).
|